Skip to main content
. 2016 Apr 27;4(2):16. doi: 10.3390/proteomes4020016

Table 2.

Altered kinase peptides by both MEK inhibitors in more than two cell lines.

Gene Symbol Position Cell Line Direction of Change
ABL2 446 A427, Calu-1 Increase
AURKA 258 Calu-6, Calu-1, H157 Decrease
CHUK 146 Calu-6, H157 Decrease
CMPK1 16 Calu-6, H157 Decrease
CSNK2A2 159 A427, H157 Increase
JAK1 718 A549, Calu-1 Increase
LATS2 793 A549, A427, Calu-1 Increase
LATS2 697 A549, A427 Increase
MAP2K2 108 A549, Calu-6 Increase
MAP2K6 181 Calu-6, A427 Increase
MAST3 492 A427, H157 Increase
NADK2 76 Calu-6, A427, Calu-1 Increase
NEK2 143 Calu-6, H157 Decrease
NEK3 131 Calu-6, H157 Decrease
PGK1 184 A549, A427 Increase
PGK1 91 A427, Calu-1 Increase
PKM 322 A427, H157 Increase
PKM 66 A549, A427 Increase
PLK1 178 A549, Calu-6, Calu-1 Decrease
PLK1 82 A549, H157 Decrease
PRKAA1 40 A427, Calu-1 Increase
PRPF4B 727 A549, Calu-1 Increase
ROCK2 1065 A427, Calu-1 Increase
STK38 118 A427, Calu-1, H157 Increase
STK38L 119 A427, Calu-1 Increase
TK1 32 Calu-6, Calu-1 Decrease
TLK1 485 Calu-6, Calu-1 Increase
ULK1 140 A549, Calu-1 Increase